Cargando…

Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan

OBJECTIVE: This study was performed to evaluate the radiological features of and therapeutic responses to pulmonary disease caused by nontuberculous mycobacteria (NTM) in the setting of biological therapy for rheumatoid arthritis (RA). METHODS: We conducted a retrospective chart review of 13 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Shunsuke, Tokuda, Hitoshi, Sakai, Fumikazu, Johkoh, Takeshi, Mimori, Akio, Nishimoto, Norihiro, Tasaka, Sadatomo, Hatta, Kazuhiro, Matsushima, Hidekazu, Kaise, Shunji, Kaneko, Atsushi, Makino, Shigeki, Minota, Seiji, Yamada, Takashi, Akagawa, Shinobu, Kurashima, Atsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440561/
https://www.ncbi.nlm.nih.gov/pubmed/22207481
http://dx.doi.org/10.1007/s10165-011-0577-6
_version_ 1782243177404563456
author Mori, Shunsuke
Tokuda, Hitoshi
Sakai, Fumikazu
Johkoh, Takeshi
Mimori, Akio
Nishimoto, Norihiro
Tasaka, Sadatomo
Hatta, Kazuhiro
Matsushima, Hidekazu
Kaise, Shunji
Kaneko, Atsushi
Makino, Shigeki
Minota, Seiji
Yamada, Takashi
Akagawa, Shinobu
Kurashima, Atsuyuki
author_facet Mori, Shunsuke
Tokuda, Hitoshi
Sakai, Fumikazu
Johkoh, Takeshi
Mimori, Akio
Nishimoto, Norihiro
Tasaka, Sadatomo
Hatta, Kazuhiro
Matsushima, Hidekazu
Kaise, Shunji
Kaneko, Atsushi
Makino, Shigeki
Minota, Seiji
Yamada, Takashi
Akagawa, Shinobu
Kurashima, Atsuyuki
author_sort Mori, Shunsuke
collection PubMed
description OBJECTIVE: This study was performed to evaluate the radiological features of and therapeutic responses to pulmonary disease caused by nontuberculous mycobacteria (NTM) in the setting of biological therapy for rheumatoid arthritis (RA). METHODS: We conducted a retrospective chart review of 13 patients from multiple centers who had developed pulmonary NTM disease during biological therapy for RA, including infliximab, etanercept, adalimumab, and tocilizumab. RESULTS: Most cases were asymptomatic or resulted in only common-cold-like symptoms. Abnormalities in computed tomography (CT) imaging were protean and frequently overlapped. The most predominant pattern was nodular/bronchiectatic disease (six cases), followed by alveolar infiltrate (three cases), cavitary disease (two cases), and pulmonary nodules (two cases). In most cases, pulmonary NTM disease had spread from a preexisting lesion; in particular, bronchial/bronchiolar abnormalities. In three cases, one or more nodular lesions with or without calcification were a focus of disease. Following the discontinuation of biological agents, most patients responded to anti-NTM therapy. Two patients showed no exacerbation in the absence of any anti-NTM therapy. In one patient, restarting tocilizumab therapy while continuing to receive adequate anti-NTM therapy produced a favorable outcome. In two other patients with a previous history of pulmonary NTM disease, introducing biological therapy led to recurrence, but anti-NTM therapy was effective in these patients. CONCLUSION: CT abnormalities of pulmonary NTM disease in RA patients receiving biological therapy were variable, but were not unique to this clinical setting. NTM disease can spread from preexisting structural abnormalities, even if they are minute. Contrary to our expectations, the therapeutic outcomes of pulmonary NTM disease were favorable in these patients.
format Online
Article
Text
id pubmed-3440561
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-34405612012-09-18 Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan Mori, Shunsuke Tokuda, Hitoshi Sakai, Fumikazu Johkoh, Takeshi Mimori, Akio Nishimoto, Norihiro Tasaka, Sadatomo Hatta, Kazuhiro Matsushima, Hidekazu Kaise, Shunji Kaneko, Atsushi Makino, Shigeki Minota, Seiji Yamada, Takashi Akagawa, Shinobu Kurashima, Atsuyuki Mod Rheumatol Original Article OBJECTIVE: This study was performed to evaluate the radiological features of and therapeutic responses to pulmonary disease caused by nontuberculous mycobacteria (NTM) in the setting of biological therapy for rheumatoid arthritis (RA). METHODS: We conducted a retrospective chart review of 13 patients from multiple centers who had developed pulmonary NTM disease during biological therapy for RA, including infliximab, etanercept, adalimumab, and tocilizumab. RESULTS: Most cases were asymptomatic or resulted in only common-cold-like symptoms. Abnormalities in computed tomography (CT) imaging were protean and frequently overlapped. The most predominant pattern was nodular/bronchiectatic disease (six cases), followed by alveolar infiltrate (three cases), cavitary disease (two cases), and pulmonary nodules (two cases). In most cases, pulmonary NTM disease had spread from a preexisting lesion; in particular, bronchial/bronchiolar abnormalities. In three cases, one or more nodular lesions with or without calcification were a focus of disease. Following the discontinuation of biological agents, most patients responded to anti-NTM therapy. Two patients showed no exacerbation in the absence of any anti-NTM therapy. In one patient, restarting tocilizumab therapy while continuing to receive adequate anti-NTM therapy produced a favorable outcome. In two other patients with a previous history of pulmonary NTM disease, introducing biological therapy led to recurrence, but anti-NTM therapy was effective in these patients. CONCLUSION: CT abnormalities of pulmonary NTM disease in RA patients receiving biological therapy were variable, but were not unique to this clinical setting. NTM disease can spread from preexisting structural abnormalities, even if they are minute. Contrary to our expectations, the therapeutic outcomes of pulmonary NTM disease were favorable in these patients. Springer Japan 2011-12-30 2012-09 /pmc/articles/PMC3440561/ /pubmed/22207481 http://dx.doi.org/10.1007/s10165-011-0577-6 Text en © Japan College of Rheumatology 2011
spellingShingle Original Article
Mori, Shunsuke
Tokuda, Hitoshi
Sakai, Fumikazu
Johkoh, Takeshi
Mimori, Akio
Nishimoto, Norihiro
Tasaka, Sadatomo
Hatta, Kazuhiro
Matsushima, Hidekazu
Kaise, Shunji
Kaneko, Atsushi
Makino, Shigeki
Minota, Seiji
Yamada, Takashi
Akagawa, Shinobu
Kurashima, Atsuyuki
Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan
title Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan
title_full Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan
title_fullStr Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan
title_full_unstemmed Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan
title_short Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan
title_sort radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in japan
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440561/
https://www.ncbi.nlm.nih.gov/pubmed/22207481
http://dx.doi.org/10.1007/s10165-011-0577-6
work_keys_str_mv AT morishunsuke radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT tokudahitoshi radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT sakaifumikazu radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT johkohtakeshi radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT mimoriakio radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT nishimotonorihiro radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT tasakasadatomo radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT hattakazuhiro radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT matsushimahidekazu radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT kaiseshunji radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT kanekoatsushi radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT makinoshigeki radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT minotaseiji radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT yamadatakashi radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT akagawashinobu radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT kurashimaatsuyuki radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan
AT radiologicalfeaturesandtherapeuticresponsesofpulmonarynontuberculousmycobacterialdiseaseinrheumatoidarthritispatientsreceivingbiologicalagentsaretrospectivemulticenterstudyinjapan